ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Pain Medicine

Top Pain Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LARISA TSAUR MD

Pain Medicine

942

$111K

91
60 are 65+

19%
patients receiving schedule two controlled substances

Avg: 30%

18%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 24%

$118
Average prescription price

Avg: $100

CHARLES KIM M.D.

Pain Medicine

480

$74.4K

52
38 are 65+

40%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$155
Average prescription price

Avg: $100

DMITRY NESEN M.D.

Pain Medicine

351

$23.9K

59
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $100

QUENTIN PHUNG MD

Pain Medicine

598

$24.4K

107
48 are 65+

21%
patients receiving schedule two controlled substances

Avg: 30%

37%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $100

DANIEL PERRI MD

Pain Medicine

1,277

$118K

140
86 are 65+

43%
patients receiving schedule two controlled substances

Avg: 30%

28%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$92
Average prescription price

Avg: $100

DENNY BATTISTA D.O.

Pain Medicine

755

$111K

172
94 are 65+

56%
patients receiving schedule two controlled substances

Avg: 30%

13%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 24%

$148
Average prescription price

Avg: $100

JEFFREY PERRY DO

Pain Medicine

270

$15.4K

124
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $100

MATTHEW KALTER M.D.

Pain Medicine

808

$90.3K

128
72 are 65+

40%
patients receiving schedule two controlled substances

Avg: 30%

22%
patients receiving schedule three controlled substances

Avg: 18%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $100

SAMANT VIRK MD

Pain Medicine

564

$46.7K

130
71 are 65+

30%
patients receiving schedule two controlled substances

Avg: 30%

8%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $100

VIDYASAGAR MOKUREDDY M.D.

Pain Medicine

762

$41.4K

264
123 are 65+

60%
patients receiving schedule two controlled substances

Avg: 30%

30%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $100

JOSEPH HERRERA D.O.

Pain Medicine

479

$64.7K

85
58 are 65+

28%
patients receiving schedule two controlled substances

Avg: 30%

18%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$135
Average prescription price

Avg: $100

MARIA CABODEVILLA-CONN MD

Pain Medicine

728

$65.5K

139
54 are 65+

65%
patients receiving schedule two controlled substances

Avg: 30%

31%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $100

KIOOMARS MOOSAZADEH MD

Pain Medicine

1,013

$64.9K

394
323 are 65+

13%
patients receiving schedule two controlled substances

Avg: 30%

12%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $100

TAHIR QAZI MD

Pain Medicine

974

$111K

68
38 are 65+

41%
patients receiving schedule two controlled substances

Avg: 30%

62%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $100

STEVEN WEINSTEIN M.D.

Pain Medicine

506

$31.2K

110
69 are 65+

25%
patients receiving schedule two controlled substances

Avg: 30%

35%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

ARASH YADEGAR M.D.

Pain Medicine

383

$26.4K

145
102 are 65+

29%
patients receiving schedule two controlled substances

Avg: 30%

23%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $100

ELIZABETH CHANDLER MD

Pain Medicine

774

$63.4K

194
49 are 65+

71%
patients receiving schedule two controlled substances

Avg: 30%

37%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$82
Average prescription price

Avg: $100

LEE TROSTERMAN MD

Pain Medicine

820

$93.5K

207
101 are 65+

34%
patients receiving schedule two controlled substances

Avg: 30%

14%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $100

CY BLANCO M.D.

Pain Medicine

522

$62.1K

138
82 are 65+

47%
patients receiving schedule two controlled substances

Avg: 30%

24%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$119
Average prescription price

Avg: $100

ENRIQUE SANZ M.D.

Pain Medicine

297

$11.3K

108
60 are 65+

16%
patients receiving schedule two controlled substances

Avg: 30%

30%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $100

STACEY JAFF M.D.

Pain Medicine

169

$13.7K

27
0 are 65+

48%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $100

GERMAINE ROWE MD

Pain Medicine

666

$62K

269
113 are 65+

52%
patients receiving schedule two controlled substances

Avg: 30%

13%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $100

ANNA KROL M.D.

Pain Medicine

293

$17.1K

63
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $100

ALEXANDER LEE MD

Pain Medicine

832

$61.5K

229
193 are 65+

15%
patients receiving schedule two controlled substances

Avg: 30%

21%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $100

JOSEPH BAX D.O.

Pain Medicine

546

$34.1K

131
78 are 65+

57%
patients receiving schedule two controlled substances

Avg: 30%

24%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank